How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?

IN BRIEF As more patents on biological medicines expire, increased numbers of biologic copies, referred to as “biosimilars,” will likely become available in the United States in the coming years. With greater availability and the drive for health care savings, the use of biosimilars and of “follow-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Triplitt, Curtis, Hinnen, Debbie, Valentine, Virginia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2017
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669137/
https://www.ncbi.nlm.nih.gov/pubmed/29109610
http://dx.doi.org/10.2337/cd16-0072
_version_ 1783275799822991360
author Triplitt, Curtis
Hinnen, Debbie
Valentine, Virginia
author_facet Triplitt, Curtis
Hinnen, Debbie
Valentine, Virginia
author_sort Triplitt, Curtis
collection PubMed
description IN BRIEF As more patents on biological medicines expire, increased numbers of biologic copies, referred to as “biosimilars,” will likely become available in the United States in the coming years. With greater availability and the drive for health care savings, the use of biosimilars and of “follow-on” biological products is likely to increase in routine clinical practice. Health care practitioners need to be fully aware of these products and accompanying considerations if they are to make informed decisions together with their patients.
format Online
Article
Text
id pubmed-5669137
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-56691372018-10-01 How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins? Triplitt, Curtis Hinnen, Debbie Valentine, Virginia Clin Diabetes Feature Articles IN BRIEF As more patents on biological medicines expire, increased numbers of biologic copies, referred to as “biosimilars,” will likely become available in the United States in the coming years. With greater availability and the drive for health care savings, the use of biosimilars and of “follow-on” biological products is likely to increase in routine clinical practice. Health care practitioners need to be fully aware of these products and accompanying considerations if they are to make informed decisions together with their patients. American Diabetes Association 2017-10 /pmc/articles/PMC5669137/ /pubmed/29109610 http://dx.doi.org/10.2337/cd16-0072 Text en © 2017 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.
spellingShingle Feature Articles
Triplitt, Curtis
Hinnen, Debbie
Valentine, Virginia
How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
title How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
title_full How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
title_fullStr How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
title_full_unstemmed How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
title_short How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
title_sort how similar are biosimilars? what do clinicians need to know about biosimilar and follow-on insulins?
topic Feature Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669137/
https://www.ncbi.nlm.nih.gov/pubmed/29109610
http://dx.doi.org/10.2337/cd16-0072
work_keys_str_mv AT triplittcurtis howsimilararebiosimilarswhatdocliniciansneedtoknowaboutbiosimilarandfollowoninsulins
AT hinnendebbie howsimilararebiosimilarswhatdocliniciansneedtoknowaboutbiosimilarandfollowoninsulins
AT valentinevirginia howsimilararebiosimilarswhatdocliniciansneedtoknowaboutbiosimilarandfollowoninsulins

Ejemplares similares